enVVeno Medical Corporation (NVNO) Stock

enVVeno Medical Corporation (NVNO) is a Healthcare stock trading at $10.51 (as of 2026-08-20), with a market capitalization of $7.18M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

enVVeno Medical Corporation is a clinical-stage medical device company developing bioprosthetic tissue-based solutions for treating venous disease. Its products include the VenoValve for surgical replacement of a venous valve and the enVVe system for non-surgical, transcatheter valve replacement, which are intended for clinical use in patients with chronic venous insufficiency.

Valuation — source: SEC EDGAR (first-party)

Price	$10.51
Market Cap	$7.18M
Price / Book	0.35
FCF Yield	-113.1%

Profitability & Growth — source: SEC EDGAR

Revenue (TTM)	$31243.00
Net Margin	-24406.7%

Valuation vs Sector & Industry

Sector P/E (Healthcare)	21.6
Industry P/E (Medical Equipment)	32.9

Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures

Top Institutional Holder	KINGDON CAPITAL MANAGEMENT, L.L.C. ($366362.00)
Institutional Holders Tracked	10

Company

Sector	Healthcare
Industry	Medical Equipment
CEO	Robert A. Berman
Employees	37
Country	US
IPO Date	2018-05-31

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

• SeaStar Medical Holding Corporation (ICU)
• Sintx Technologies, Inc. (SINT)
• Intelligent Bio Solutions Inc. (INBS)
• Co-Diagnostics, Inc. (CODX)
• Picard Medical, Inc. (PMI)
• Autonomix Medical, Inc. Common Stock (AMIX)
• Bluejay Diagnostics, Inc. (BJDX)
• Catheter Precision, Inc. (VTAK)

Data as of 2026-08-20.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.